window.dataLayer = window.dataLayer || []; function gtag(){dataLayer.push(arguments);} gtag('js', new Date()); gtag('config', 'G-4PR1PSYQLJ'); Skip to content

Welcome to Discover Pharma! Today is : September 12, 2026

  • News
  • Featured News Archives
    • 12 Days of Christmas
    • Women in Pharma
  • About Us
Contact Us

Drug Development

  • Drug Discovery & Development,Genomics and sequencing,Research & Development

    Tagomics launches cfDNA platform for multi-organ drug safety monitoring

    Tagomics has launched a cell-free DNA platform designed to monitor [...]

    August 17, 2026
  • Clinical & Regulatory,Digital & Data,Drug Discovery & Development,Research & Development

    Tufts analysis finds AI clinical monitoring could cut trial costs and development time

    A Tufts CSDD analysis estimates that an AI clinical monitoring [...]

    August 13, 2026
  • Digital & Data,Drug Discovery & Development,Manufacturing & Supply Chain,Research & Development

    CN Bio wins Innovate UK grant to develop human-relevant drug testing workflow

    CN Bio has secured a £180,000 Innovate UK grant to [...]

    August 13, 2026
  • Biotech & Pharma Business,Clinical & Regulatory,Drug Discovery & Development,Pharmaceuticals and therapeutics,Research & Development,Therapeutic Areas

    Vaderis raises $152M and starts Phase 3 trial of engasertib in HHT

    Vaderis Therapeutics has raised $152M and started a global Phase [...]

    August 12, 2026
  • Drug Discovery & Development,Pharmaceuticals and therapeutics,Research & Development,Therapeutic Areas

    Almirall and CrystalO partner on small-molecule drug discovery in dermatology

    Almirall has entered a drug discovery collaboration with CrystalO to [...]

    August 17, 2026
  • Central Nervous System,Drug Discovery & Development,Research & Development

    AstronauTx exercises Saniona option for neurological disease candidate

    AstronauTx has exercised its option to acquire worldwide rights to [...]

    August 10, 2026
  • Biotech & Pharma Business,Clinical & Regulatory,Digital & Data,Drug Discovery & Development,Research & Development

    QuantHealth raises $45M Series B to expand AI clinical trial simulation

    QuantHealth has raised $45 million in a Series B funding [...]

    August 4, 2026
  • Biotech & Pharma Business,Drug Discovery & Development,Research & Development

    Circio advances circular RNA gene therapy platform towards clinical development

    Circio is preparing to advance its circular RNA gene therapy [...]

    August 4, 2026
  • Clinical & Regulatory,Drug Discovery & Development,Genomics and sequencing,Pharmaceuticals and therapeutics,Research & Development,Therapeutic Areas

    Medicus Pharma gets UAE approval to start genomics-guided endometriosis study

    Medicus Pharma has received authorisation from the UAE Department of [...]

    July 31, 2026
  • Clinical & Regulatory,Drug Discovery & Development,Pharmaceuticals and therapeutics,Research & Development

    Verdiva Bio starts Phase 1 trial of once-weekly oral amylin drug for obesity

    Verdiva Bio has dosed the first patient in a Phase [...]

    July 30, 2026
Previous123Next

Bringing you the latest industry news and insights every day

Registered Address: Discover Pharma Ltd, 1 Dartmouth Close, Brighton, BN2 4HZ, UK
Company Number: 16239596

  • About Us
  • Contact Us
  • Legal
    • Cookie Policy
    • Privacy Policy
    • Terms & Conditions
  • Author Guidelines
    • Pharmaceutical Author Guidelines
    • Press Release Advice
  • Advertise with Us
  • Media Kit Request

© 2026 Discover Pharma. All rights reserved • Developed by Hairy Goat Design

Page load link

Press “ESC” key to close

main menu
  • Home
  • News
  • About Us
  • Contact
recent posts
  • How AI is reshaping clinical trials: Saama on the next phase of regulated AI
    Categories: Clinical & Regulatory, Digital & Data, Drug Discovery & Development, Research & Development
  • MRI study suggests some prostate cancer biopsies could eventually be avoided
    Categories: Clinical & Regulatory, Medical devices, Research & Development, Therapeutic Areas
  • START and Allegheny Health Network to expand access to early-phase cancer trials
    Categories: Clinical & Regulatory, Pharmaceuticals and therapeutics, Therapeutic Areas
get connected
This website uses cookies and third party services. See our Cookie Policy and Privacy Policy pages for details.
OK
Go to Top